NCT01253369 Pazopanib in Patients With Relapsed or Refractory Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT01250717 Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer Status COMPLETED Phase PHASE2
NCT01239394 Ofatumumab for Initial Systemic Treatment of Indolent B-cell Lymphoma Status COMPLETED Phase PHASE2
NCT01228500 The Use of Bioscaffolds in Conjunction With Negative Pressure Therapy: A Prospective Randomized Double-Blinded Trial Status WITHDRAWN Phase NA
NCT01215149 Safety and Immunogenicity Study of Ad26-ENVA and Ad35-ENV HIV Vaccines in Healthy HIV-uninfected Adults Status COMPLETED Phase PHASE1
NCT01208662 Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT01206322 Enhancement of Cerebral Vasoreactivity and Cognition by Intranasal Insulin in Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT01187771 Apnea, Bariatric Surgery Versus Continuous Positive Airway Pressure (CPAP) Trial Status COMPLETED Phase PHASE2
NCT01184326 Expanded Phase I Pazopanib and Everolimus in Advanced Solid Tumors and Previously Treated Advanced Urothelial Cancer Status COMPLETED Phase PHASE1
NCT01174576 Acute Effects of Coffee on Appetite and Inflammation Markers, Glucose Metabolism and Energy Intake Status COMPLETED Phase NA
NCT01173679 Dasatinib With Fludarabine and Rituximab in Relapsed and Refractory CLL and SLL Status TERMINATED Phase PHASE2
NCT01173523 Study of Hsp90 Inhibitor, STA-9090 for Relapsed or Refractory Small Cell Lung Cancer Status COMPLETED Phase PHASE2